U.S. FDA Grants Traditional Approval to Leqembi (Lecanemab-Irmb) for Alzheimer's Disease Treatment. BONITA SPRINGS, FL July 6, 2023 - FDA Grants Traditional Approval to Leqembi (Lecanemab-Irmb) for Alzheimer's Disease Treatment. In a groundbreaking move, Leqembi has received traditional approval from the FDA for the treatment of Alzheimer's...
Memory Treatment Centers at the forefront of Alzheimer's treatment innovation, as featured in the Wall Street Journal Memory Treatment Centers neurologist, Jamie Plante and current Leqembi patient were interviewed by the Wall Street Journal to investigate availability of new Alzheimers treatments. With the recent FDA approval...
Memory Treatment Centers, a leading neurocognitive disease clinic, is proud to be one of the first medical organizations in the United States to offer the innovative Alzheimer’s drug Leqembi (lecanemab-irmb). Bonita Springs, FL February 6, 2023 - Last week, Memory Treatment Centers (MTC) became amongst the...
Memory Treatment Centers Applauds U.S. FDA Approval of Leqembi (Lecanemab) BONITA SPRING, FL, January 10, 2023 — Memory Treatment Centers are pleased to announce that the Food and Drug Administration (FDA) has approved Lecanemab, a new drug for the treatment of Alzheimer's disease. This is an important...
SALT LAKE CITY, Aug. 9, 2021 /PRNewswire/ -- Memory Treatment Centers, a PURE Healthcare company (PURE), is excited to announce the completion of their first Aduhelm infusion. Memory Treatment Centers are among the first organizations to administer the new FDA approved Alzheimer's drug, Aduhelm. The infusion took place...